Spero Therapeutics Announces Fourth Quarter and Full Year 2025 Operating Results and Provides a Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. IBM
6. MU
7. FDX
8. BLZE
9. NKE
10. PRIM

Go back to Spero Therapeutics Announces Fourth Quarter and Full Year 2025 Operating Results and Provides a Business Update

Spero Therapeutics (SPRO) Tops Q4 EPS by 73c, Beats on Revenue

March 26, 2026 4:13 PM EDT

Spero Therapeutics (NASDAQ: SPRO) reported Q4 EPS of $0.53, $0.73 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $41.3 million versus the consensus estimate of $26 million.

For earnings history and earnings-related data on SmartPros Ltd. (SPRO) click here.

... More